Asian Phytoceuticals PCL (BKK:APCO-R) Total Assets: ฿648.7 Mil (As of Mar. 2026)


BKK:APCO-R Asian Phytoceuticals PCL BKK:APCO-R
62 GF Score
Price ฿6.27
GF Value ฿7.46
! 4 Warning Signs
View Full Analysis

What is Asian Phytoceuticals PCL Total Assets?

Asian Phytoceuticals PCL BKK:APCO-R 62 Total Assets is ฿648.7 Mil as of Mar. 2026. GuruFocus rates BKK:APCO-R with a GF Score™ of 62/100 and a GF Value™ of ฿7.46. The stock has 4 warning signs investors should review.

Asian Phytoceuticals PCL's Total Assets for the quarter that ended in Mar. 2026 was ฿648.7 Mil.

During the past 12 months, Asian Phytoceuticals PCL's average Total Assets Growth Rate was -12.30% per year. During the past 3 years, the average Total Assets Growth Rate was -18.80% per year. During the past 5 years, the average Total Assets Growth Rate was -13.90% per year. During the past 10 years, the average Total Assets Growth Rate was 8.90% per year.

During the past 13 years, Asian Phytoceuticals PCL's highest 3-Year average Total Assets Growth Rate was 49.50%. The lowest was -18.80%. And the median was 3.80%.

Total Assets is connected with ROA %. Asian Phytoceuticals PCL's annualized ROA % for the quarter that ended in Mar. 2026 was 11.00%. Total Assets is also linked to Revenue through Asset Turnover. Asian Phytoceuticals PCL's Asset Turnover for the quarter that ended in Mar. 2026 was 0.08.

Asian Phytoceuticals PCL  (BKK:APCO-R) Total Assets Explanation

Total Assets is connected with ROA %.

Asian Phytoceuticals PCL's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=70.236/( (627.736+648.719)/ 2 )
=70.236/638.2275
=11.00 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Asian Phytoceuticals PCL's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=49.547/( (627.736+648.719)/ 2 )
=49.547/638.2275
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Asian Phytoceuticals PCL Total Assets Related Terms

Asian Phytoceuticals PCL Total Assets Historical Data

* Premium members only.

The historical data trend for Asian Phytoceuticals PCL's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Asian Phytoceuticals PCL Total Assets Chart

Asian Phytoceuticals PCL Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 680.53 680.15 704.72 636.02 627.74

Asian Phytoceuticals PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 645.63 597.87 609.19 627.74 648.72
BKK:APCO-R
62GF Score
Asian Phytoceuticals PCL BKK:APCO-R
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Asian Phytoceuticals PCL Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Asian Phytoceuticals PCL's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=560.193+67.543
=627.7

Asian Phytoceuticals PCL's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=578.813+69.906
=648.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of ฿648.7 Mil mean?
Asian Phytoceuticals PCL (BKK:APCO-R) has a Total Assets of ฿648.7 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Asian Phytoceuticals PCL and its competitors.
Is Asian Phytoceuticals PCL's Total Assets too high?
Asian Phytoceuticals PCL's current Total Assets is ฿648.7 Mil. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Total Assets compare to PG and CL?
Asian Phytoceuticals PCL's Total Assets of ฿648.7 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Consumer Packaged Goods company?
A good Total Assets depends on the Consumer Packaged Goods industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Asian Phytoceuticals PCL and its competitors. Asian Phytoceuticals PCL's current Total Assets is ฿648.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Total Assets of ฿648.7 Mil. The stock's GF Value™ is ฿7.46, compared to a current price of ฿6.27 — trading 15.9% below its estimated fair value. The current Total Assets is ฿648.7 Mil. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Total Assets is ฿648.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?

Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued. The current stock price of ฿6.27 is trading 15.9% below its estimated GF Value™ of ฿7.46.

Key valuation signals for BKK:APCO-R:

  • Total Assets: ฿648.7 Mil
  • GF Value™: ฿7.46 vs. price of ฿6.27 (15.9% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Asian Phytoceuticals PCL Business Description

Other Exchanges APCO:Thailand
Address 84/3 Moo 4 Highway No.11 Road, Northern Region Industrial Estate West, Banklang, Muang Lamphun, Lumphun, THA, 51000
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score

Get the complete analysis for BKK:APCO-R

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿6.27
Price
฿7.46
GF Value